Mr Balaggan specialises in state of-the-art modern micro-incision sutureless vitrectomy surgery, and micro-incision and femtolaser-assisted cataract and lens replacement surgery.
BSc(Hons), MBBS, FRCOphth, PhD
Mr Balaggan provides completely comprehensive surgical and laser treatment of:
- Vitreomacular traction
- Floaters and vitreous syneresis/ detachment
- Macular holes
- Epiretinal membranes
- Complex and routine emergency retinal detachments and retinal tears
- Diabetic retinal detachments
He is also fully trained to treat most medical retina conditions including providing intravitreal injection and laser therapies for:
- Macular degeneration
- Retinal vein occlusions
- Diabetic retinopathy
- Diabetic maculopathy
- Inherited/genetic retinal disorders
Mr. Balaggan is a Consultant Ophthalmologist who is unique in being one of exceptionally few surgeons that have completed not just two years of prestigious high-volume Fellowships in Vitreoretinal Surgery, but also two years of subspecialist Fellowship training in Medical Retina, all at the internationally-renowned Moorfields Eye Hospital, London. This was in addition to his general ophthalmic training, which was also predominantly based at this Centre of Excellence and one of the world’s top eye hospitals. He also obtained a PhD from University College London (ranked in the top 5 universities globally) developing state-of-the-art Gene Therapy for age-related macular degeneration as well as other retinal disorders. He has been awarded numerous prizes recognising his contribution to advancing frontiers in ophthalmology and for his teaching excellence. He is considered an expert in retinal medicine and surgery, and has often been invited to lecture both nationally and internationally, teaching other retinal specialists.
Research and teaching
Mr Balaggan has an outstanding track-record in research and teaching. He spent four years full-time at University College London, under the guidance of internationally-awarded Professor Robin Ali, performing cutting-edge research developing novel retinal gene-based therapies for age-related macular degeneration and inherited retinal disorders. He was awarded a PhD for this work and has authored 30 peer-reviewed publications, 12 as first-author, including 7 in the prestigious journals Nature Medicine, and New England Journal of Medicine, Ophthalmology and British Journal of Ophthalmology. He has given numerous lectures nationally and internationally related to his research.
Mr. Balaggan was a co-investigator in the world’s first gene therapy trial for an inherited retinopathy (New England Journal of Medicine 2008, 2015), and more recently a key investigator in the first randomised clinical evaluation of subconjunctival bevacizumab for new onset corneal neovascularisation (British Journal of Ophthalmology, 2012 ).
He co-designed and is the Principal Investigator in a new clinical trial which will be based at Moorfields Eye Hospital, and which will evaluate a novel radiotherapy device for the treatment of macular degeneration.
He is also a peer-reviewer for 6 ophthalmology scientific journals.
Mr Balaggan is the recipient of six local, national and international prizes in recognition of the quality of his research, including the highly prestigious:
- Moorfields Eye Hospital Research Medal (awarded for the best research by any resident),
- Royal College of Ophthalmologists Foulds Trophy (awarded for the best original research presentation)
- Best Paper Presentation American Academy of Ophthalmology
- Best Surgical Video Prize Euretina
- Allergan Research Fellowship Award (1st Runner up)
Mr Balaggan is also passionate about teaching other ophthalmologists and trainee doctors, and was awarded the prize of Best NHS Tutor of the Year 2012 by Bart’s and the London Medical School in recognition of his teaching skills and enthusiasm.
See the full list of Mr Balaggan’s research publications
Overseas charity work
Mr Balaggan is involved in charitable eye camp organisation and delivery, restoring precious sight to citizens blinded by cataract in India.
Member of societies
- Fellow of The Royal College of Ophthalmologists (RCOphth)
- Member of The British and Eire Association of Vitreoretinal Surgeons (BEAVRS)
- Member of The Association for Research in Vision and Ophthalmology (ARVO)
- Member of The American Academy of Ophthalmology (AAO)
- Fully registered with a license to Practice with the General Medical Council (GMC)